News | November 21, 2025
EMA launches streamlined process to fast-track critical medicines, vaccines
The move is expected to be crucial during health crises
The move is expected to be crucial during health crises
All drug substance for Moderna’s authorized Spikevax (COVID-19 mRNA vaccine) targeting the SARS-CoV-2 LP.8.1 variant is produced at the company’s facility in Laval, Quebec
The updated formula for Spikevax is now approved for individuals 6 months through 64 years of age
This termination of Agreement will not have any significant impact on the company and/or its subsidiaries or its financials
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
BAV has revolutionized the animal vaccination industry with its ground-breaking delivery methods that prioritize quality, safety, and efficacy
GSK and Flagship to jointly fund up to $150 million upfront
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Subscribe To Our Newsletter & Stay Updated
